Health Boards
Good news for those in the UK waiting for Taltz The National Institute for Health and Care excellence (NICE) are about to approve it for use on psoriasis patients.
The key dates for this appraisal are:
Closing date for comments: 22 November 2016
Second appraisal committee meeting: 25 January 2017
Until final guidance is issued, NHS organizations should make decisions locally on the funding of specific treatments.
Source: nice.org.uk
Taltz (ixekizumab)
The key dates for this appraisal are:
Closing date for comments: 22 November 2016
Second appraisal committee meeting: 25 January 2017
Until final guidance is issued, NHS organizations should make decisions locally on the funding of specific treatments.
Source: nice.org.uk
Taltz (ixekizumab)